Collaboration aims to enhance bioavailability and support clinical advancement of Clearmind’s lead MEAI candidate for addiction-related and other ...

Collaboration aims to leverage Polyrizon’s advanced proprietary intranasal delivery platform to support clinical development of Clearmind’s drug ...

The “moving sofa problem,” a puzzle that has remained unresolved since it was introduced in 1966 and memorably illustrated in ...

Neuropathic pain, often referred to as nerve pain, can arise from a range of conditions such as diabetic neuropathy, nerve ...

When a medication doesn’t exist in the right dose, form or formulation, patients are left with few options – a challenge in ...

Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a ...

In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

From autonomous cars to video games, reinforcement learning (machine learning through interaction with environments) can have ...

"An important part of science helping to find solutions." Scientists develop game-changing solution to major problem with ...

Veradermics is set to raise $200 million in an IPO to fund its novel extended-release oral minoxidil for pattern hair loss.

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Leading academics from universities and research organizations across Europe and America, and companies and SMEs interested ...